Hayfin Capital Management

Hayfin Capital Management is an independent investment firm headquartered in London that provides lending solutions to European middle-market companies and asset management services to institutional clients. Founded in 2009, it operates a European-focused platform with offices in London, Paris, Madrid, Frankfurt, Amsterdam, Luxembourg and Tel Aviv, and maintains a growing presence in the United States with New York. The firm concentrates on four credit strategies: Direct Lending, Special Opportunities, High-Yield Credit and Securitized Credit. It emphasizes value investing through rigorous analysis and disciplined investing, with a network-driven origination approach and specialized teams in healthcare, shipping and real estate to manage complex restructurings, workouts and liquidations. Hayfin aims to deliver risk-adjusted returns for investors and attract talented professionals across its markets.

Atin Dhawan

Investment Analyst

Timothy Flynn

Co-Founder, CEO and Member of Executive Committee

Olaf Hartmann

Portfolio Manager and Managing Director

Mark Tognolini

Co-Founder, COO and Member, Management Committee

Andrew Merrill

Managing Director, Healthcare

17 past transactions

HeartFlow

Convertible Note in 2025
HeartFlow specializes in precision heart care, offering a non-invasive solution for diagnosing coronary artery disease. Its proprietary HeartFlow FFRCT Analysis uses artificial intelligence to create a personalized 3D model of the heart, enabling clinicians to evaluate blood flow and determine optimal treatment. Commercially available in the United States, UK, Canada, Europe, and Japan.

MolecuLight

Venture Round in 2025
MolecuLight specializes in innovative imaging solutions for wound care, focusing on the detection of harmful bacteria and accurate wound measurement. The company develops portable handheld optical imaging devices that allow medical practitioners to visualize bacteria and assess wound status directly at the point of care. These devices facilitate the analysis and visual detection of bacteria, provide procedural guidance, and enable the assessment of viable and nonviable tissue. By offering these capabilities, MolecuLight supports healthcare professionals in selecting appropriate therapies for their patients and effectively monitoring wound healing progress.

Cosette Pharmaceuticals

Debt Financing in 2024
Cosette Pharmaceuticals is a specialized generic pharmaceutical company focusing on dermatology and allergy treatments. It offers a diverse portfolio of branded pharmaceuticals, primarily targeting women's health and cardiology, alongside its core dermatology products. The company's product range includes creams, ointments, lotions, solutions, gels, pastes, suppositories, and oral liquids. With comprehensive capabilities in product development and commercial operations, Cosette Pharmaceuticals aims to effectively meet the drug needs of clients in the dermatology and allergy sectors.

Xeris Biopharma

Post in 2024
Xeris Biopharma is a specialty pharmaceutical company developing ready-to-use, liquid-stable injectables using its proprietary XeriSol and XeriJect formulation technologies. These platforms enable subcutaneous and intramuscular delivery of various drugs, offering advantages such as room temperature stability, reduced injection volume, and ease of use for patients and healthcare practitioners.

HeartFlow

Series F in 2023
HeartFlow specializes in precision heart care, offering a non-invasive solution for diagnosing coronary artery disease. Its proprietary HeartFlow FFRCT Analysis uses artificial intelligence to create a personalized 3D model of the heart, enabling clinicians to evaluate blood flow and determine optimal treatment. Commercially available in the United States, UK, Canada, Europe, and Japan.

KEO World

Venture Round in 2022
KEO World is a FinTech company based in Miami, Florida, that specializes in all-digital inventory financing and B2B payment solutions. The company aims to facilitate business growth for both buyers and suppliers by providing innovative financial services across the U.S., Mexico, and Latin America through its Global Trade program. KEO World leverages artificial intelligence and machine learning to analyze banking transactional data, allowing it to offer loans and instant funding to businesses and consumers quickly and efficiently. By streamlining the financing process, KEO World enhances access to capital, ultimately supporting the financial needs of its clients in a rapidly evolving market.

ADMA Biologics

Post in 2022
ADMA Biologics, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing specialty plasma-derived biologics aimed at treating immune deficiencies and infectious diseases in the United States. The company offers a range of products, including BIVIGAM and ASCENIV, both intravenous immune globulin therapies for primary humoral immunodeficiency, as well as Nabi-HB, which is used for acute exposure to Hepatitis B. ADMA is also involved in the development of additional plasma-derived therapeutics, particularly targeting infections like S. pneumonia. To support its operations, the company runs FDA-licensed source plasma collection facilities known as ADMA BioCenters, which contribute to the supply of plasma necessary for its product manufacturing. ADMA Biologics distributes its products through independent distributors, sales agents, specialty pharmacies, and other healthcare providers. Founded in 2004 and based in Ramsey, New Jersey, ADMA is dedicated to serving niche patient populations, particularly those with compromised immune systems.

KEO World

Debt Financing in 2022
KEO World is a FinTech company based in Miami, Florida, that specializes in all-digital inventory financing and B2B payment solutions. The company aims to facilitate business growth for both buyers and suppliers by providing innovative financial services across the U.S., Mexico, and Latin America through its Global Trade program. KEO World leverages artificial intelligence and machine learning to analyze banking transactional data, allowing it to offer loans and instant funding to businesses and consumers quickly and efficiently. By streamlining the financing process, KEO World enhances access to capital, ultimately supporting the financial needs of its clients in a rapidly evolving market.

Avadim Health

Acquisition in 2021
Avadim Health, Inc. is a healthcare and wellness company based in Asheville, North Carolina, specializing in the development, manufacturing, and marketing of topical products aimed at improving immune health, neuromuscular health, and skin barrier health. Utilizing its proprietary Bionome Engineered Platform, the company offers a diverse range of therapeutic skincare products that address various health concerns, including pain, infections, muscle cramps, spasms, restless leg symptoms, and joint discomfort. Avadim Health serves both institutional and consumer markets, distributing its products through retail outlets such as grocery stores and pharmacies, as well as acute-care hospitals, nursing homes, and online channels. Founded in 2007 and originally known as Avadim Technologies, the company rebranded to Avadim Health in September 2018, reflecting its broader focus on health and wellness solutions.

Frans Bonhomme

Acquisition in 2020
Frans Bonhomme is a French distributor based in Joué-lès-Tours that supplies a broad range of piping and drainage products. The company offers PVC and PE pipes and fittings, as well as networks made from PVC, PP and cast iron, along with corrugated pipes, manholes, and related wastewater, rainwater, and drainage equipment. Its product lines extend to network accessories and various plumbing, heating, sanitation, sealing, and pumping components. Frans Bonhomme serves the water-supply sector, covering drainage, drinking water, rainwater, and wastewater applications, and focuses on delivering quality products to support infrastructure and utility installations.

Amicus Therapeutics

Post in 2020
Amicus Therapeutics is a biotechnology company focused on discovering, developing, and delivering therapies for rare and orphan diseases. It specializes in oral pharmacological chaperones—small molecules that bind, stabilize, and enhance activity of misfolded enzymes—to treat lysosomal storage disorders such as Fabry and Pompe disease, and it explores combination approaches with enzyme replacement therapy. The company maintains a growing pipeline targeting additional lysosomal diseases, including Gaucher, and collaborates with academic and clinical partners to advance its programs. Amicus was founded in 2002 and is headquartered in Cranbury, New Jersey.

MiMedx Group

Post in 2020
MiMedx Group develops and markets regenerative biologics derived from human placental tissue, utilizing patent-protected processes. Its products include EpiFix and AmnioFix for wound care, along with other allografts for various healthcare sectors such as orthopedics, sports medicine, and ophthalmics. The company sells its products through direct sales channels and independent distributors.

GC Aesthetics

Venture Round in 2018
GC Aesthetics PLC is a Dublin-based company that specializes in the development, manufacturing, and commercialization of silicone breast implants and related products for women. Founded in 2015, the company offers a comprehensive range of surgical implants, tissue expanders, and silicone products designed for breast augmentation, aesthetic enhancement, and reconstructive purposes. Additionally, GC Aesthetics provides innovative solutions for scar management and a variety of patient support products to facilitate informed decision-making regarding surgery. With over 30 years of industry expertise, the company is committed to empowering women on their body transformation journeys and prioritizes innovation in its product offerings. GC Aesthetics serves both surgeons and patients in Ireland and across international markets, with manufacturing facilities located in Scotland, England, and France.

Avadim Health

Debt Financing in 2018
Avadim Health, Inc. is a healthcare and wellness company based in Asheville, North Carolina, specializing in the development, manufacturing, and marketing of topical products aimed at improving immune health, neuromuscular health, and skin barrier health. Utilizing its proprietary Bionome Engineered Platform, the company offers a diverse range of therapeutic skincare products that address various health concerns, including pain, infections, muscle cramps, spasms, restless leg symptoms, and joint discomfort. Avadim Health serves both institutional and consumer markets, distributing its products through retail outlets such as grocery stores and pharmacies, as well as acute-care hospitals, nursing homes, and online channels. Founded in 2007 and originally known as Avadim Technologies, the company rebranded to Avadim Health in September 2018, reflecting its broader focus on health and wellness solutions.

Kingsland Capital Management

Acquisition in 2017
Kingsland Capital Management is an employee-owned investment manager specializing in fixed income markets. The company provides investment management services for funds and collateralized loan obligations, focusing on high yield, leveraged loans, distressed assets, and mezzanine investments. Kingsland Capital employs both fundamental and technical analysis to construct its portfolios, aiming to optimize returns through strategic investment in corporate debt securities and other asset classes.

NKD

Debt Financing in 2015
NKD Group is a retailer and local supplier specializing in textiles and home accessories. The company offers a diverse range of fashionable products for the entire family, including clothing for men, women, and children, as well as functional sportswear and home textiles. NKD's product selection emphasizes affordability and includes seasonal items like traditional costumes and trendy garments. Customers can shop conveniently through both online and offline platforms, where they can find a variety of apparel and home goods designed to meet various tastes and needs. The company is committed to providing value prices while regularly updating its inventory with new fashion trends and seasonal decorations.

Novetude Sante Group

Novetude Santé Group is a French organization that operates a network of higher education institutions focused on training healthcare professionals. Established in 2009 and headquartered in Paris, the group provides a range of educational services. Its offerings include preparatory classes for medical and paramedical exams, diploma courses in osteopathy, and vocational training in fields such as optics, dietetics, social and family economy, prosthetics, and dental assistance. Additionally, Novetude Santé Group emphasizes continuing education to enhance the skills of health professionals, ensuring they remain updated with the latest practices and knowledge in their respective fields.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.